Archive · 19 Aug 2026
Novonesis Plans ₹3,000-Crore Maharashtra Investment Over Three Years
Novonesis is a company that makes biological products for industries such as farming, food and fuel.
It plans to invest up to ₹3,000 crore in Maharashtra.
The investment is expected to happen over the next two to three years.
Much of the expansion may take place at its Patalganga factory.
The company wants to make more enzymes, yeast and health and nutrition ingredients.
Its products can help ethanol makers produce fuel more efficiently.
Novonesis is also testing products for sugarcane, biogas and agricultural uses.
The company says slow and unclear approvals can make it harder to introduce biological products for farming.
Novonesis plans to invest ₹2,500-3,000 crore in Maharashtra over the next 24-36 months.
The Patalganga manufacturing site is expected to receive a significant share of the expansion.
Remaining project approvals and sign-offs are expected to be completed in 2026.
The company sees opportunities in biofuels, food, health, agriculture and biogas solutions.
Novonesis Regional President Krishna Mohan Puvvada called regulation a key constraint for agricultural biologicals.
- Who
- Novonesis, represented by Regional President Krishna Mohan Puvvada.
- What
- A planned ₹2,500-3,000 crore investment and capacity expansion in Maharashtra.
- When
- The investment is planned over the next 24-36 months; the report was published August 19, 2026.
- Where
- Maharashtra, particularly Novonesis's Patalganga manufacturing site; the company also operates at Wada.
- Why
- To expand capacity and meet growing demand for biofuels, food and health solutions, agricultural biologicals and related products in India.
Expansion And Innovation Case
Regulatory Caution
Maharashtra investment
Expansion And Innovation Case
Novonesis plans the investment as part of an expansion aimed at capturing growing demand across biofuels, food, health, agriculture and biogas.
Regulatory Caution
The company has not yet announced the detailed allocation of the investment, pending remaining approvals and sign-offs.
Agricultural biologicals
Expansion And Innovation Case
Novonesis says biological solutions can improve sugarcane yields and support alternatives to conventional chemical processes.
Regulatory Caution
Krishna Mohan Puvvada says agricultural biologicals face lengthy approvals and are often assessed under regulatory frameworks designed for chemicals.
Bioenergy performance
Expansion And Innovation Case
The company says newer yeast technologies can shorten fermentation by about 25%, while biogas trials have shown output improvements of more than 15% to 25-30% in some cases.
Regulatory Caution
The reported benefits vary according to feedstock and operating conditions, so results are not uniform across applications.
- Planned investment
- ₹2,500-3,000 crore
- Investment timeline
- 24-36 months
- Key site
- Patalganga, Maharashtra
- Other Maharashtra operation
- Wada
- Company formation
- Novonesis was formed through the 2024 merger of Novozymes and Chr. Hansen.
- Global organic sales ambition
- 6-9% growth
- Sugarcane yield claim
- A biological solution launched in Karnataka is reported by the company to increase yields by about 15%